Peer Comparison
| Company | Market Price | MCAP(Cr) | P/B | P/E | EPS | ROE |
|---|---|---|---|---|---|---|
| JBCHEPHARM | 2116.75(0.0%) | 16,361 | 6.7 | 42.1 | 25.5 | 19.9 |
| AJANTPHARM | 1313.75(0.0%) | 16,524 | 5.6 | 29.6 | 27.4 | 19.3 |
| SANOFI | 6840(0.0%) | 15,765 | 11.2 | 27.5 | 59.8 | 40.8 |
| GLENMARK | 609.6(0.6%) | 17,178 | 1.0 | 14.2 | 14.2 | 12.3 |
| GLAND | 932.45(-0.2%) | 15,353 | 1.9 | 19.8 | 24.8 | 18.6 |
| PFIZER | 3810.25(0.0%) | 17,437 | 5.4 | 27.9 | 54.2 | 38.7 |
| IPCALAB | 705.5(0.0%) | 17,825 | 3.0 | 35.2 | 20.4 | 17.9 |
| LAURUSLABS | 340.5(0.0%) | 18,333 | 4.5 | 24.1 | 26.0 | 28.1 |
| PEL | 782.45(-0.5%) | 18,658 | 0.8 | 1.3 | 7.7 | 3.9 |
| SUVENPHAR | 474.2(0.0%) | 12,071 | 6.9 | 27.9 | 44.5 | 37.8 |
| NATCOPHARM | 622.95(0.0%) | 11,155 | 2.5 | 17.5 | 17.5 | 14.4 |
| APLLTD | 548.85(-1.1%) | 10,773 | 2.4 | 31.1 | 28.9 | 23.3 |
| GLAXO | 1327.2(0.0%) | 22,486 | 12.8 | 37.2 | 37.7 | 18.4 |
| MEDPLUS | 803.85(0.0%) | 9,601 | 8.4 | 0.0 | 16.6 | 9.1 |
| ASTRAZEN | 3502.5(0.0%) | 8,749 | 14.9 | 88.1 | 31.2 | 22.8 |
